- SUBSTITUTED OXOPYRIDINE DERIVATIVES
-
The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
- -
-
Paragraph 0887-0890
(2017/11/07)
-
- SUBSTITUTED OXOPYRIDINE DERIVATIVES
-
The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.
- -
-
Paragraph 0842; 0843; 0844; 0845
(2017/10/27)
-
- TRIAZOLYL DERIVATIVES AS SYK INHIBITORS
-
Provided are triazole derivatives of Formula I which are potent inhibitors of spleen tyrosine kinase and pharmaceutical composition. The triazole derivatives are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis, and cancer.
- -
-
Page/Page column 95
(2014/04/17)
-
- NEW COMPOUNDS
-
The present invention relates to new compounds of formula I, wherein P Q X1 X2 X3 X4 X5 R R1 R2 R3 R4R5 G M1 M2 M3 m and n are defined as in formula I, a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
- -
-
-
- Use of substituted 1,2,4-oxadiazole derivatives for combating endoparasites, new substituted 1,2,4-oxadiazole derivatives, and processes for their preparation
-
The present invention relates to the use of substituted 1,2,4-oxadiazole derivatives of the general formula I STR1 in which R1 represents hydrogen, alkyl which is optionally substituted by halogen, alkoxy, hydroxyl, amino, alkylamino, dialkylam
- -
-
-